documents: FDA-2026-N-5816-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-5816-0002 FDA FDA-2026-N-5816 Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction Notice Correction 2026-10-09T04:00:00Z 2026 10 2026-10-09T04:00:00Z   2026-10-09T18:36:17Z 2026-20730 0 0 09000064b965774f

Links from other tables